Merit Medical Systems MMSI announces its next round of earnings Monday. Here is Benzinga's everything-that-matters guide for the Q2 earnings announcement.
Earnings and Revenue
Based on Merit Medical Systems management projections, analysts predict EPS of 40 cents on revenue of $214.67 million.
If the company were to post earnings inline with the current consensus estimate when it reports Monday, EPS would be up 11.11 percent. Revenue would be up 15.07 percent on a year-over-year basis. Here's how the company's reported EPS has stacked up against analyst estimates in the past:
| Quarter | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 |
| EPS Estimate | 0.29 | 0.32 | 0.3 | 0.29 |
| EPS Actual | 0.31 | 0.33 | 0.32 | 0.36 |
Stock Performance
Over the last 52-week period, shares are up 44.56 percent. Given that these returns are generally positive, long-term shareholders should be content going into this earnings release. Analyst estimates are adjusted higher for EPS and revenues over the past 90 days. Analysts have been rating Merit Medical Systems stock as Neutral. The strength of this rating has maintained conviction over the past three months.
Conference Call
Don't be surprised to see the stock move on comments made during its conference call. Merit Medical Systems's Q2 conference call is scheduled to begin at 5:00 p.m. ET.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
